Gene · 8529
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients. | Int J Surg | 2023 | 37598356 | PubTator, text mining | PubMed |
| Promises and challenges in pharmacoepigenetics. | Camb Prism Precis Med | 2023 | 37560024 | PubTator, text mining | PubMed |
| A genome-wide association study identifies 41 loci associated with eicosanoid levels. | Commun Biol | 2023 | 37524825 | PubTator, text mining | PubMed |
| Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia. | Medicine (Baltimore) | 2023 | 37505171 | PubTator, text mining | PubMed |
| The STROMICS genome study: deep whole-genome sequencing and analysis of 10K Chinese patients with ischemic stroke reveal complex genetic and phenotypic interplay. | Cell Discov | 2023 | 37479695 | PubTator, text mining | PubMed |
| Responsiveness to endurance training can be partly explained by the number of favorable single nucleotide polymorphisms an individual possesses. | PLoS One | 2023 | 37471354 | PubTator, text mining | PubMed |
| Computational pharmacogenotype extraction from clinical next-generation sequencing. | Front Oncol | 2023 | 37469403 | PubTator, text mining | PubMed |
| Metabolomic Analysis of Vitamin E Supplement Use in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | Nutrients | 2023 | 37447163 | PubTator, text mining | PubMed |
| Label-Free Raman Spectromicroscopy Unravels the Relationship between MGMT Methylation and Intracellular Lipid Accumulation in Glioblastoma. | Anal Chem | 2023 | 37417930 | PubTator, text mining | PubMed |
| Computational Structural Validation of CYP2C9 Mutations and Evaluation of Machine Learning Algorithms in Predicting the Therapeutic Outcomes of Warfarin. | Curr Drug Metab | 2023 | 37409551 | PubTator, text mining | PubMed |
| Byproducts of Sesame Oil Extraction: Composition, Function, and Comprehensive Utilization. | Foods | 2023 | 37372594 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
| One Rare Warfarin Resistance Case and Possible Mechanism Exploration. | Pharmgenomics Pers Med | 2023 | 37359384 | PubTator, text mining | PubMed |
| Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China. | Pharmgenomics Pers Med | 2023 | 37342180 | PubTator, text mining | PubMed |
| Efficacy of Warfarin Therapy Guided by Pharmacogenetics: A Real-world Investigation Among Han Taiwanese. | Clin Ther | 2023 | 37301690 | PubTator, text mining | PubMed |
| The pharmacogenomic landscape of an Indigenous Australian population. | Front Pharmacol | 2023 | 37284308 | PubTator, text mining | PubMed |
| Side-Chain Modification in Conjugated Polymer Frameworks for the Electrocatalytic Oxygen Evolution Reaction. | ACS Appl Mater Interfaces | 2023 | 37278535 | PubTator, text mining | PubMed |
| Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies. | Clin Pharmacokinet | 2023 | 37273173 | PubTator, text mining | PubMed |
| High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium. | Exp Eye Res | 2023 | 37271310 | PubTator, text mining | PubMed |
| Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis. | Curr Cardiol Rep | 2023 | 37261665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8529/papers?page=7